About

Publications While At HealthPartners

selected publications

Journal Article

Twice-daily triple nucleoside intensification treatment with lamivudine-zidovudine plus abacavir sustains suppression of human immunodeficiency virus type 1: results of the TARGET Study. 

Journal of Infectious Diseases. 2001

Contact

full name

R. L. Fisher

Quick Info

 

Collaboration

Co-author network

Map of science